Drug Shelf Life Effect On Cost Uncertain, AMA Report Finds
This article was originally published in The Tan Sheet
Executive Summary
Additional research is needed to determine whether longer drug product shelf lives would lower drug costs, the American Medical Association Council on Scientific Affairs says in a report prepared for the AMA House of Delegates meeting in Chicago June 17-21.
You may also be interested in...
Drug Expiration Date Rationale Requested By Waxman
Data on FDA's expiration date policies and safety/ effectiveness standards for OTC and Rx drugs are requested by Rep. Henry Waxman (D-Calif.) in a May 19 letter to FDA.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands